دورية أكاديمية

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

التفاصيل البيبلوغرافية
العنوان: HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
المؤلفون: Pasqua, A. Elisa, Sharp, Swee Y., Chessum, Nicola E. A., Hayes, Angela, Pellegrino, Loredana, Tucker, Michael J., Miah, Asadh, Wilding, Birgit, Evans, Lindsay E., Rye, Carl S., Mok, N. Yi, Liu, Manjuan, Henley, Alan T., Gowan, Sharon, De Billy, Emmanuel, te Poele, Robert, Powers, Marissa, Eccles, Suzanne A., Clarke, Paul A., Raynaud, Florence I., Workman, Paul, Jones, Keith, Cheeseman, Matthew D.
المساهمون: Cancer Research UK, Battle Against Cancer Investment Trust, Cancer Research Technology Pioneer Fund
المصدر: Journal of Medicinal Chemistry ; volume 66, issue 8, page 5907-5936 ; ISSN 0022-2623 1520-4804
بيانات النشر: American Chemical Society (ACS)
سنة النشر: 2023
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1021/acs.jmedchem.3c00156
الإتاحة: https://doi.org/10.1021/acs.jmedchem.3c00156Test
حقوق: https://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.540635A4
قاعدة البيانات: BASE